Downloads
Article: Continuous Manufacturing for Secondary Processes: Leapfrog Time?
By Rebecca Vangenechten and Ivo Backx
Pharmaceutical secondary manufacturing has long stood in stark contrast to the drug discovery end of the business, as well as to other sectors, when it comes to innovation such as continuous manufacturing. Is that about to change? Siemens' Rebecca Vangenechten and Ivo Backx argue that the coming decade could see secondary manufacturing not just catch up but leapfrog other sectors but that mindset will be a crucial factor.
Used with permission from Life Science Leader magazine.
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get access to this piece of content and thousands of additional articles and product reviews across our entire network of sites.
